25 April 2025 in IEEE Transactions on Medical Imaging
Domain shift is a significant challenge in medical image segmentation, primarily due to variations in image acquisition protocols, modalities, etc. Domain shift often causes models trained on a source domain to perform poorly on unseen target domains. In this work, we introduce the Domain-Generalized Discrete Diffusion Model for Segmentation (DG-DDM-Seg), a diffusion-based generative model designed for single-source domain generalization in medical image segmentation. DG-DDM-Seg generates discrete conditional distributions of segmentation masks. To ensure domain independence, we employ two key strategies: 1) We extract robust features from conditional images to enhance the domain independence of diffusion model. 2) We use both conditional images and pseudo-labels as inputs to improve cross-domain segmentation performance. Along this idea, we propose a two-path reverse diffusion process during training, utilizing Robust Feature Extraction Subnet and Mask-Generation Transformer to learn a domain-generalized discrete conditional distribution based on robust image features and pseudo-labels. This learned distribution is then used to generate segmentation masks for unseen target domains. Experimental results demonstrate that DG-DDM-Seg achieves state-of-the-art performance in cross-domain medical image segmentation, with domain shifts in modality, sequence, and site. The code is available at https://github.com/HeranYang/DG-DDM-Seg.
6 April 2025 in Communications Biology
Understanding disease progression is crucial for detecting critical transitions and finding trigger molecules, facilitating early diagnosis interventions. However, the high dimensionality of data and the lack of aligned samples across disease stages have posed challenges in addressing these tasks. We present a computational framework, Gaussian Graphical Optimal Transport (GGOT), for analyzing disease progressions. The proposed GGOT uses Gaussian graphical models, incorporating protein interaction networks, to characterize the data distributions at different disease stages. Then we use population-level optimal transport to calculate the Wasserstein distances and transport between stages, enabling us to detect critical transitions. By analyzing the per-molecule transport distance, we quantify the importance of each molecule and identify trigger molecules. Moreover, GGOT predicts the occurrence of critical transitions in unseen samples and visualizes the disease progression process. We apply GGOT to the simulation dataset and six disease datasets with varying disease progression rates to substantiate its effectiveness. Compared to existing methods, our proposed GGOT exhibits superior performance in detecting critical transitions.